These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 30785037)
1. Chondroitin sulfate-functionalized polymeric nanoparticles for colon cancer-targeted chemotherapy. Zu M; Ma L; Zhang X; Xie D; Kang Y; Xiao B Colloids Surf B Biointerfaces; 2019 May; 177():399-406. PubMed ID: 30785037 [TBL] [Abstract][Full Text] [Related]
2. Silencing of Intestinal Glycoprotein CD98 by Orally Targeted Nanoparticles Enhances Chemosensitization of Colon Cancer. Xiao B; Viennois E; Chen Q; Wang L; Han MK; Zhang Y; Zhang Z; Kang Y; Wan Y; Merlin D ACS Nano; 2018 Jun; 12(6):5253-5265. PubMed ID: 29860836 [TBL] [Abstract][Full Text] [Related]
3. Enhanced antitumor efficacy in colon cancer using EGF functionalized PLGA nanoparticles loaded with 5-Fluorouracil and perfluorocarbon. Wu P; Zhou Q; Zhu H; Zhuang Y; Bao J BMC Cancer; 2020 Apr; 20(1):354. PubMed ID: 32345258 [TBL] [Abstract][Full Text] [Related]
4. Hyaluronic acid-functionalized polymeric nanoparticles for colon cancer-targeted combination chemotherapy. Xiao B; Han MK; Viennois E; Wang L; Zhang M; Si X; Merlin D Nanoscale; 2015 Nov; 7(42):17745-55. PubMed ID: 26455329 [TBL] [Abstract][Full Text] [Related]
5. Oral administration of chondroitin sulfate-functionalized nanoparticles for colonic macrophage-targeted drug delivery. Zhang X; Ma Y; Ma L; Zu M; Song H; Xiao B Carbohydr Polym; 2019 Nov; 223():115126. PubMed ID: 31426992 [TBL] [Abstract][Full Text] [Related]
6. Anticancer activity of polymeric nanoparticles containing linoleic acid-SN38 (LA-SN38) conjugate in a murine model of colorectal cancer. Cheng G; Zhang X; Chen Y; Lee RJ; Wang J; Yao J; Zhang Y; Zhang C; Wang K; Yu B Colloids Surf B Biointerfaces; 2019 Sep; 181():822-829. PubMed ID: 31247407 [TBL] [Abstract][Full Text] [Related]
7. iRGD-functionalized PEGylated nanoparticles for enhanced colon tumor accumulation and targeted drug delivery. Ma L; Chen Q; Ma P; Han MK; Xu Z; Kang Y; Xiao B; Merlin D Nanomedicine (Lond); 2017 Aug; 12(16):1991-2006. PubMed ID: 28745123 [TBL] [Abstract][Full Text] [Related]
8. In vitro evaluation of paclitaxel loaded amorphous chitin nanoparticles for colon cancer drug delivery. Smitha KT; Anitha A; Furuike T; Tamura H; Nair SV; Jayakumar R Colloids Surf B Biointerfaces; 2013 Apr; 104():245-53. PubMed ID: 23337120 [TBL] [Abstract][Full Text] [Related]
9. Preparation, characterisation and in vitro and in vivo evaluation of CD44-targeted chondroitin sulphate-conjugated doxorubicin PLGA nanoparticles. Liu P; Chen N; Yan L; Gao F; Ji D; Zhang S; Zhang L; Li Y; Xiao Y Carbohydr Polym; 2019 Jun; 213():17-26. PubMed ID: 30879657 [TBL] [Abstract][Full Text] [Related]
10. CD147 Monoclonal Antibody Targeted Reduction-Responsive Camptothecin Polyphosphoester Nanomedicine for Drug Delivery in Hepatocellular Carcinoma Cells. Tian H; Huang Y; He J; Zhang M; Ni P ACS Appl Bio Mater; 2021 May; 4(5):4422-4431. PubMed ID: 35006854 [TBL] [Abstract][Full Text] [Related]
11. Targeted rod-shaped mesoporous silica nanoparticles for the co-delivery of camptothecin and survivin shRNA in to colon adenocarcinoma in vitro and in vivo. Babaei M; Abnous K; Taghdisi SM; Taghavi S; Sh Saljooghi A; Ramezani M; Alibolandi M Eur J Pharm Biopharm; 2020 Nov; 156():84-96. PubMed ID: 32882423 [TBL] [Abstract][Full Text] [Related]
12. Development and evaluation of camptothecin loaded polymer stabilized nanoemulsion: Targeting potential in 4T1-breast tumour xenograft model. Sugumaran A; Ponnusamy C; Kandasamy P; Krishnaswami V; Palanichamy R; Kandasamy R; Lakshmanan M; Natesan S Eur J Pharm Sci; 2018 Apr; 116():15-25. PubMed ID: 28987538 [TBL] [Abstract][Full Text] [Related]
13. Redox-responsive amphiphilic camptothecin prodrug nanoparticles for targeted liver tumor therapy. Lu L; Li B; Lin C; Li K; Liu G; Xia Z; Luo Z; Cai K J Mater Chem B; 2020 May; 8(17):3918-3928. PubMed ID: 32227058 [TBL] [Abstract][Full Text] [Related]
14. Bile acid-conjugated chondroitin sulfate A-based nanoparticles for tumor-targeted anticancer drug delivery. Lee JY; Chung SJ; Cho HJ; Kim DD Eur J Pharm Biopharm; 2015 Aug; 94():532-41. PubMed ID: 26149228 [TBL] [Abstract][Full Text] [Related]
15. PHBV/PLGA nanoparticles for enhanced delivery of 5-fluorouracil as promising treatment of colon cancer. Handali S; Moghimipour E; Rezaei M; Ramezani Z; Dorkoosh FA Pharm Dev Technol; 2020 Feb; 25(2):206-218. PubMed ID: 31648589 [TBL] [Abstract][Full Text] [Related]
16. Co-delivery of 5-fluorouracil and oxaliplatin in novel poly(3-hydroxybutyrate-co-3-hydroxyvalerate acid)/poly(lactic-co-glycolic acid) nanoparticles for colon cancer therapy. Handali S; Moghimipour E; Rezaei M; Saremy S; Dorkoosh FA Int J Biol Macromol; 2019 Mar; 124():1299-1311. PubMed ID: 30248424 [TBL] [Abstract][Full Text] [Related]
17. SN38 polymeric nanoparticles: in vitro cytotoxicity and in vivo antitumor efficacy in xenograft balb/c model with breast cancer versus irinotecan. Sepehri N; Rouhani H; Tavassolian F; Montazeri H; Khoshayand MR; Ghahremani MH; Ostad SN; Atyabi F; Dinarvand R Int J Pharm; 2014 Aug; 471(1-2):485-97. PubMed ID: 24879937 [TBL] [Abstract][Full Text] [Related]
18. Preparation of camptothecin-loaded targeting nanoparticles and their antitumor effects on hepatocellular carcinoma cell line H22. Yang A; Liu Z; Yan B; Zhou M; Xiong X Drug Deliv; 2016 Jun; 23(5):1699-706. PubMed ID: 25148540 [TBL] [Abstract][Full Text] [Related]
19. Chondroitin sulfate-hybridized zein nanoparticles for tumor-targeted delivery of docetaxel. Lee HS; Kang NW; Kim H; Kim DH; Chae JW; Lee W; Song GY; Cho CW; Kim DD; Lee JY Carbohydr Polym; 2021 Feb; 253():117187. PubMed ID: 33278965 [TBL] [Abstract][Full Text] [Related]
20. Cell Surface Nucleolin as a Promising Receptor for Effective AS1411 Aptamer-Mediated Targeted Drug Delivery into Cancer Cells. Mosafer J; Mokhtarzadeh A Curr Drug Deliv; 2018; 15(9):1323-1329. PubMed ID: 30039760 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]